199 related articles for article (PubMed ID: 32980362)
41. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
42. Thyrotropic action of human chorionic gonadotropin.
Yoshimura M; Hershman JM
Thyroid; 1995 Oct; 5(5):425-34. PubMed ID: 8563483
[TBL] [Abstract][Full Text] [Related]
43. The use of plasmapheresis for rapid hormonal control in severe hyperthyroidism caused by a partial molar pregnancy.
Adali E; Yildizhan R; Kolusari A; Kurdoglu M; Turan N
Arch Gynecol Obstet; 2009 Apr; 279(4):569-71. PubMed ID: 18726107
[TBL] [Abstract][Full Text] [Related]
44. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
45. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
46. The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic disease.
Nishimura R; Endo Y; Tanabe K; Ashitaka Y; Tojo S
J Endocrinol Invest; 1981; 4(3):349-58. PubMed ID: 7320438
[TBL] [Abstract][Full Text] [Related]
47. [Hyperthyroidism in molar pregnancy].
Boufettal H; Mahdoui S; Noun M; Hermas S; Samouh N
Rev Med Interne; 2014 Mar; 35(3):202-5. PubMed ID: 24074966
[TBL] [Abstract][Full Text] [Related]
48. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
[TBL] [Abstract][Full Text] [Related]
49. Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole.
Raj R; Uy EM; Hager M; Asadipooya K
Case Rep Endocrinol; 2019; 2019():2941501. PubMed ID: 31949957
[TBL] [Abstract][Full Text] [Related]
50. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
51. Choriocarcinoma following ovarian hydatidiform mole: a case report.
Joneborg U; Papadogiannakis N; Lindell G; Marions L
J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
[TBL] [Abstract][Full Text] [Related]
52. Hyperthyroidism in a complete molar pregnancy with a mature cystic ovarian teratoma.
Simes BC; Mbanaso AA; Zapata CA; Okoroji CM
Thyroid Res; 2018; 11():12. PubMed ID: 30116304
[TBL] [Abstract][Full Text] [Related]
53. Clinical presentation and diagnosis of Gestational Trophoblastic Disease.
Lok C; Frijstein M; van Trommel N
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():42-52. PubMed ID: 33422446
[TBL] [Abstract][Full Text] [Related]
54. Gonadotropin-releasing hormone-induced elevation of serum hCG in choriocarcinoma: a case report.
Furuhashi M; Miyabe Y; Katsumata Y; Oda H; Imai N
Endocr J; 1998 Aug; 45(4):585-90. PubMed ID: 9881911
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
56. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
Yuen BH; Cannon W; Benedet JL; Boyes DA
Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
[TBL] [Abstract][Full Text] [Related]
57. Thyroid storm as an early presentation of hCG-producing metastatic choriocarcinoma: a case report and review of the literature.
Chivukula KK; Toro-Tobón D; Motazedi B; Goyal R
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34580125
[TBL] [Abstract][Full Text] [Related]
58. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
59. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
60. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
